AstraZeneca PLC (AZN) — Stock Price, Chart & Analysis
AstraZeneca PLC (AZN) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $250.34B and a trailing P/E ratio of 24.16. Over the past 52 weeks, AZN has traded between $145.80 and $212.71. AstraZeneca PLC pays a dividend yielding 2.0%. View the live AZN chart, technical opinion, analyst ratings, fundamentals and latest news below.
AstraZeneca PLC (AZN) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $250.34B |
| P/E ratio (TTM) | 24.16 |
| EPS (TTM) | $6.68 |
| Dividend yield | 2.0% |
| 52-week high | $212.71 |
| 52-week low | $145.80 |
| Beta | 0.21 |
| Avg. volume | 2.70M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about AstraZeneca PLC (AZN)
How much does one share of AstraZeneca PLC cost?
As of the latest update, one share of AstraZeneca PLC (AZN) trades at $100 (+0.00% today).
What is AstraZeneca PLC's market cap?
AstraZeneca PLC has a market capitalization of approximately $250.34B.
What is AstraZeneca PLC's P/E ratio?
AstraZeneca PLC has a trailing price-to-earnings (P/E) ratio of 24.16.
What is AstraZeneca PLC's earnings per share (EPS)?
AstraZeneca PLC's trailing twelve-month EPS is $6.68.
Does AstraZeneca PLC pay a dividend?
Yes — AstraZeneca PLC pays a dividend with a yield of 2.0% ($3.19 per share annually).
What is AstraZeneca PLC's 52-week trading range?
Over the past year, AZN has traded between $145.80 and $212.71.
What is the analyst price target for AstraZeneca PLC?
The mean analyst price target for AstraZeneca PLC is $213.69. This is informational only and not investment advice.
Latest AstraZeneca PLC (AZN) news
- The 20-year exodus hollowing out the London stock marketNews · Aug 7, 2026
- What the AstraZeneca-BMS rumors reveal about pharma megamergersNews · Aug 6, 2026
- AstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’News · Aug 5, 2026
- European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East DevelopmentsNews · Aug 5, 2026
- AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationNews · Aug 5, 2026
- Roche Stock Jumps as Morgan Stanley Sees Drug BreakoutNews · Aug 7, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live AZN dashboard…